NCT02557633View on ClinicalTrials.gov

A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2016

Conditions
Allergic Rhinitis
Interventions
BIOLOGICAL

Grass MATA MPL 10200

BIOLOGICAL

Grass MATA MPL 18200

BIOLOGICAL

Placebo

Trial Locations (2)

07753

Inflamax Research, Inc., Neptune City

07105

Inflamx Research, Newark

Sponsors
All Listed Sponsors
collaborator

Inflamax Research Incorporated

INDUSTRY

collaborator

Metronomia Clinical Research GMBH

UNKNOWN

lead

Allergy Therapeutics

INDUSTRY